Image (198e8618 C012 4f1c 9365 84c1829893c0 01)
Spironolactone Tablet
Product Images NDC 64980-708
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 64980-708). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image (198e8618 C012 4f1c 9365 84c1829893c0 02)
Image (198e8618 C012 4f1c 9365 84c1829893c0 03)
This text appears to show data on the subgroup level hazard ratio (HR) and 95% confidence interval (CI) for Spironolactone and Placebo. The data likely indicates the comparative effectiveness between Spironolactone and Placebo in a study or trial.*
25 mg 30's (198e8618 C012 4f1c 9365 84c1829893c0 04)
This is a product description for Spironolactone tablets. Each film-coated tablet contains 25 mg of Spironolactone USP. The tablets are to be stored below 77°F (25°C) and protected from light. They should be dispensed in tight, light-resistant, and child-resistant containers. Prescribing information should be consulted for dosage and use instructions. The tablets are manufactured by Graviti Pharmaceuticals Pvt. Ltd. in Telangana, India, and distributed by Rising Pharma Holdings in East Brunswick, NJ. The product's label indicates an issuance date of 03/2025.*
50mg 30's (198e8618 C012 4f1c 9365 84c1829893c0 05)
This is information about Spironolactone tablets, containing 50mg of Spironolactone USP. The tablets are film-coated and come in a pack of 100 tablets. The dosage and usage instructions can be found in the accompanying prescribing information. These tablets should be stored below 77°F (25°C) and protected from light. They are dispensed in tight, light-resistant, child-resistant containers. The product is manufactured by Graviti Pharmaceuticals Pvt Ltd in Telangana, India, and distributed by Rising Pharma Holdings, Inc. in East Brunswick, NJ, USA. The batch was issued in March 2025.*
100mg 30's (198e8618 C012 4f1c 9365 84c1829893c0 06)
This is information about Spironolactone tablets USP containing 100 mg per tablet. The tablets should be stored below 77°F (25°C) and protected from light. They should be dispensed in light-resistant, child-resistant containers. The tablets are manufactured by Graviti Pharmaceuticals Pvt Ltd in Telangana, India and distributed by Rising Pharma Holdings, Inc in East Brunswick, NJ. The issuing date of the information is 03/2025. Further dosage and prescribing information can be found in the accompanying document.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
